II Annual Immunooncology Congress
Ciudad Obregón Sonora, México -- Preliminary program --
Workshops: Thursday December 1st
Congress: Friday December 2nd and Saturday December 3rdnd.
Thursday, December 1st, 2016
WORKSHOP part 1
Chairperson: Gardenia Vargas Parra, MD, PhD.
11:00 a.m.-12:00 p.m. On-site Registration
12:00 p.m.-12:30 p.m. Immuno-Oncology 101 for clinicians
Juan Pablo Márquez Manríquez, MD. Sonora Cancer Research Center, Seattle, WA, USA.
12:30 p.m.-12:45 p.m. Questions & Answers
12:45 p.m.-1:15 p.m. Checkpoint inhibitors in lung cancer and other neoplasias
Omar Macedo Pérez, MD. Mexican National Cancer Institute, Mexico City.
1:15 p.m.-1:45 p.m. Questions & Answers
Keynote Speaker Presentation
Chairperson: Joel Hernandez Rivera, MD, Ms.
1:45 p.m.-2:45 p.m. Inflammatory breast cancer
Jaime de la Garza Salazar, MD. Mexican National Cancer Institute, Mexico City.
2:45 p.m.-3:45 p.m. LUNCH BREAK 2
WORKSHOP part 2
Chairperson: Alberto Durazo Acuna, MD.
4:00 p.m.-4:30 p.m. Immunogenic chemotherapy in solid tumors
Pedro Alejandro Lucero Diaz, MD. Sonora Cancer Research Center, Ciudad Obregon, Sonora
4:30 p.m.-4:45 p.m. Questions & Answers
4:45 p.m.-5:15 p.m. Adjuvants in cancer Immunotherapy
Esteban Celis, MD, PhD. Georgia Cancer Center, Augusta, GA, USA
5:15 p.m.-5:30 p.m. Questions & Answers
5:30 p.m.-6:00 p.m. Clinical importance of immune infiltration in solid tumors
Jose Antonio Matute Briceño, MD. Sonora Cancer Research Center, Ciudad Obregon, Sonora
6:00 p.m.-6:15 p.m. Questions & Answers
8:00 p.m.-10:00 p.m. Dinner
Sponsored by: Oncologia Molecular Avanzada
Friday, December 2nd, 2016
Opening remarks from the lead collaborators of the Sonoran Community
Chairperson: Manuel López Loaiza, BS, MS.
8:00 a.m.-9:20 a.m.
Maria Trevino Munoz, President of the Board of Directors of the Sonora Cancer Research Center
Karmen Aida Diaz Brown, BS. Sonora State Congresswoman
Edgar Fabian Manriquez Barreras. Ciudad Obregon CANACO President
Salvador Icedo Zamora, MD. Ciudad Obregon General Hospital Director 3
Juan Carlos Galvez Ruiz, PhD. UNISON Health Science Department, Campus Cajeme
Perspective from a cancer patient relative
Jose Enrique Rodarte Salazar, BS. Philanthropist
Plenary Session 1: Introduction to Immuno-Oncology
Chairperson: Dolores Gallardo Rincon, MD.
9:20 a.m.-10:00 a.m. Immunology for oncologists
Juan Pablo Marquez Manriquez, MD. Sonora Cancer Research Center, Seattle, WA, USA
10:00 a.m.-10:45 a.m. The link between genetics and immunogenicity
Gardenia Vargas Parra, MD, PhD. Sonora Cancer Research Center, Ciudad Obregon, Sonora
10:45 a.m.-11:30 a.m. CAR-T cells strategies for cancer immunotherapy
Travis Young, PhD. California Institute for Biomedical Research, La Jolla, CA, USA
11:30 a.m.-12:15 p.m. ChemoFit test: Validation of a chemo sensitivity assay for solid tumors
Arvind Thakur, PhD. AccuTheranostics, Clinical & Translational Research Center, Buffalo, NY, USA
12:15 p.m.-1:00 p.m. Repurposing drugs with immune properties for hematological malignancies
Alejandro Camacho Hernandez, MD. Sonora Cancer Research Center, Ciudad Obregon, Sonora
1:00 p.m.-1:15 p.m. Session Discussion
1:15 p.m.-2:00 p.m. LUNCH 4
Plenary Session 2: Immunopharmacology in Cancer Immunotherapy
Chairperson: Francisco Javier Ochoa Carrillo, MD.
2:00 p.m.-2:30 p.m. Clinical immunopharmacology of antibiotics with immunooncology properties
Pedro Alejandro Lucero Díaz, MD. Sonora Cancer Research Center, Ciudad Obregon, Sonora
2:30 p.m.-3:00 p.m. Immunotherapeutic targets for neurotumors
Alberto Durazo Acuña, MD. Sonora Cancer Research Center, Seattle, WA, USA
3:00 p.m.-3:30 p.m. Immunotherapeutic targets in pancreatic ductal adenocarcinoma
Erik Ramos, MD. Sonora Cancer Research Center, Seattle, WA, USA
3:30 p.m.-4:30 p.m. Immunosuppressive pathways in hepatocellular carcinoma patients and beneficial immunomodulation following sorafenib therapy
Keynote Speaker: Yasmin Thanavala, MD, PhD. Roswell Park Cancer Institute, Buffalo, NY, USA
4:30 p.m.-5:00 p.m. Secondary effects of the cancer immunotherapy agents
Jorge Martinez Tlahuel, MD, PhD. Mexican National Cancer Institute, Mexico City
5:00 p.m.-5:15 p.m. Session Discussion
5:15 p.m.-5:45 p.m. Development and optimization of T cell immunotherapy and vaccines for ovarian cancer
Arturo Suplee, MD. Sonora Cancer Research Center, Seattle, WA, USA
5:45 p.m.-6:30 p.m. Ovarian cancer and relapse pattern
Maria Dolores Gallardo Rincon, MD. National Cancer Institute, Mexico City
7:30 p.m.-11:30 p.m. Immunooncology 2016 GALA
Sponsored by: CICS Campus Seattle, WA, USA 5
Saturday, December 3rd, 2016
Plenary Session 3: Immune infiltrate and cancer
Chairperson: Raquel Gerson, M.D.
8:00 a.m.-8:45 a.m. Lymphocytic infiltration in colorectal cancer
Luis F. Oñate Ocaña, MD. Mexican National Cancer Institute, Mexico City
8:45 a.m.-9:45 a.m. Engineering better T cells and tumors for adoptive immunotherapy
Keynote speaker: Brad Nelson, PhD. University of British Columbia Canada
9:45 a.m.-10:45 a.m. An oasis in the immune desert: Tumor antigen expression and spontaneous immune responses in patients with T cell-poor ovarian tumors
David Kroeger, PhD. University of British Columbia, Canada
10:45 a.m.-11:30 a.m. Immuno-Oncology in pediatric malignancies: collaborations are going to start
Adriana Bello Cedres, MD. Trinidad Medical Center, Caracas, Venezuela
11:30 a.m.-12:30 p.m. Understanding and neutralizing cancer induced immunosuppression to promote anti-tumoral immunity
Keynote speaker: Suzanne Ostrand-Rosenberg, PhD. University of Maryland, Baltimore, USA
12:30 p.m.-12:45 p.m. Session Discussion
12:45 p.m.-1:45 p.m. LUNCH BREAK
Chairperson: Claudia Arce Salinas, M.D. 6
1:45 p.m.-2:30 p.m. Blocking β-adrenergic receptor signaling restores endogenous immune control of murine tumor models and improves responses to anti-PD-1 checkpoint blockade in mice housed at sub-thermoneutral housing temperatures
Mark J. Bucsek, BS. Roswell Park Cancer Institute, Buffalo, NY, USA
2:30 p.m.-3:30 p.m. Adrenergic stress signaling in laboratory mice results in immunosuppression and an increase in the resistance of experimental tumors to radiation and chemotherapy
Keynote Speaker: Elizabeth Repasky, PhD. Roswell Park Cancer Institute, Buffalo, NY, USA
3:30 p.m.-4:30 p.m. Designing therapeutic cancer vaccines by mimicking viral infections
Keynote speaker: Esteban Celis, MD, PhD. Georgia Cancer Center, Augusta, GA, USA
4:30 p.m.-4:45 p.m. Session Discussion
4:45 p.m.-5:00 p.m. Poster awards presentation
Closing remarks and Departure
Chairperson: Arturo Suplee Rivera, MD.
5:00 p.m.-5:35 p.m. Juan Pablo Marquez Manriquez, MD. Sonora Cancer Research Center, Seattle, WA, USA
Faustino Felix Chavez. Cajeme County Mayor.
Claudia Pavlovich Arellano. Governor of the State of Sonora 7